{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:41:08Z","timestamp":1778895668075,"version":"3.51.4"},"reference-count":49,"publisher":"The Editorial Office of Gut and Liver","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut Liver"],"published-print":{"date-parts":[[2015,5,23]]},"DOI":"10.5009\/gnl13408","type":"journal-article","created":{"date-parts":[[2014,7,29]],"date-time":"2014-07-29T04:21:53Z","timestamp":1406607713000},"source":"Crossref","is-referenced-by-count":5,"title":["Expression of TIM-3, Human \u03b2-defensin-2, and FOXP3 and Correlation with Disease Activity in Pediatric Crohn's Disease with Infliximab Therapy"],"prefix":"10.5009","volume":"9","author":[{"given":"Mi Jin","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo Yong","family":"Lee","sequence":"additional","affiliation":[{"name":"Departments of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yon Ho","family":"Choe","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2920","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature06005","article-title":"Unravelling the pathogenesis of inflammatory bowel disease","volume":"448","author":"Xavier, RJ","year":"2007","journal-title":"Nature"},{"issue":"Suppl 1","key":"ref2","doi-asserted-by":"crossref","first-page":"i16","DOI":"10.1136\/gut.2005.081950b","article-title":"European evidence based consensus on the diagnosis and management of Crohn\u2019s disease: current management","volume":"55","author":"Travis, SP","year":"2006","journal-title":"Gut"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1053\/j.gastro.2006.02.014","article-title":"Infliximab plus azathioprine for steroid-dependent Crohn\u2019s disease patients: a randomized placebo-controlled trial","volume":"130","author":"L\u00e9mann, M","year":"2006","journal-title":"Gastroenterology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00535-009-0138-3","article-title":"Evolving paradigms in the pathogenesis of IBD","volume":"45","author":"Mayer, L","year":"2010","journal-title":"J Gastroenterol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00535-007-2111-3","article-title":"Inflammatory bowel disease, past, present and future: lessons from animal models","volume":"43","author":"Mizoguchi, A","year":"2008","journal-title":"J Gastroenterol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.med.51.1.289","article-title":"Role of cytokines in the pathogenesis of inflammatory bowel disease","volume":"51","author":"Papadakis, KA","year":"2000","journal-title":"Annu Rev Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0016-5085(98)70381-6","article-title":"Inflammatory bowel disease: etiology and pathogenesis","volume":"115","author":"Fiocchi, C","year":"1998","journal-title":"Gastroenterology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/415536a","article-title":"Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease","volume":"415","author":"Monney, L","year":"2002","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.coi.2006.09.009","article-title":"TIM-3 in autoimmunity","volume":"18","author":"Anderson, AC","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/ni987","article-title":"Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance","volume":"4","author":"S\u00e1nchez-Fueyo, A","year":"2003","journal-title":"Nat Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1172\/JCI25308","article-title":"Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis","volume":"116","author":"Chen, Y","year":"2006","journal-title":"J Clin Invest"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1189\/jlb.1006610","article-title":"Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17","volume":"81","author":"Nakae, S","year":"2007","journal-title":"J Leukoc Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ni1271","article-title":"The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity","volume":"6","author":"Zhu, C","year":"2005","journal-title":"Nat Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.clim.2009.09.012","article-title":"Involvement of T cell Ig Mucin-3 (Tim-3) in the negative regulation of inflammatory bowel disease","volume":"134","author":"Li, X","year":"2010","journal-title":"Clin Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1084\/jem.20061531","article-title":"Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta","volume":"204","author":"Nadkarni, S","year":"2007","journal-title":"J Exp Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2567.2007.02778.x","article-title":"Special regulatory T-cell review: regulatory T cells and the intestinal tract--patrolling the frontier","volume":"123","author":"Izcue, A","year":"2008","journal-title":"Immunology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/1074-7613(95)90156-6","article-title":"Severe colitis in mice with aberrant thymic selection","volume":"3","author":"Holl\u00e4nder, GA","year":"1995","journal-title":"Immunity"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.4049\/jimmunol.170.8.3939","article-title":"Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells","volume":"170","author":"Mottet, C","year":"2003","journal-title":"J Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori, S","year":"2003","journal-title":"Science"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot, JD","year":"2003","journal-title":"Nat Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/MOG.0b013e328136c580","article-title":"Defensins and other antimicrobial peptides in inflammatory bowel disease","volume":"23","author":"Wehkamp, J","year":"2007","journal-title":"Curr Opin Gastroenterol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0161-5890(03)00156-1","article-title":"Intestinal defensin gene expression in human populations","volume":"40","author":"Dhaliwal, W","year":"2003","journal-title":"Mol Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrmicro976","article-title":"Primate defensins","volume":"2","author":"Lehrer, RI","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"ref24","first-page":"3178","article-title":"Innate and adaptive immunity in inflammatory bowel disease","volume":"17","author":"Siegmund, B","year":"2011","journal-title":"World J Gastroenterol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.immuni.2006.05.017","article-title":"Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology","volume":"25","author":"Uhlig, HH","year":"2006","journal-title":"Immunity"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1084\/jem.20061099","article-title":"Interleukin-23 drives innate and T cell-mediated intestinal inflammation","volume":"203","author":"Hue, S","year":"2006","journal-title":"J Exp Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.4049\/jimmunol.177.5.2760","article-title":"Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis","volume":"177","author":"Becker, C","year":"2006","journal-title":"J Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.MPG.0000163736.30261.82","article-title":"Inflammatory bowel disease in children and adolescents: recommendations for diagnosis--the Porto criteria","volume":"41","author":",","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00005176-199105000-00005","article-title":"Development and validation of a pediatric Crohn\u2019s disease activity index","volume":"12","author":"Hyams, JS","year":"1991","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0167-5699(97)01102-X","article-title":"Th1-Th2: reliable paradigm or dangerous dogma?","volume":"18","author":"Allen, JE","year":"1997","journal-title":"Immunol Today"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1471-4906(01)01980-9","article-title":"Th1- or Th2-cell commitment during infectious disease: an oversimplification?","volume":"22","author":"Rook, G","year":"2001","journal-title":"Trends Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1517\/14728222.11.8.1005","article-title":"TIM-3 as a therapeutic target in human inflammatory diseases","volume":"11","author":"Anderson, DE","year":"2007","journal-title":"Expert Opin Ther Targets"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3109\/00365521.2011.568518","article-title":"Dysregulated upregulation of T-cell immunoglobulin and mucin domain-3 on mucosal T helper 1 cells in patients with Crohn\u2019s disease","volume":"46","author":"Morimoto, K","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1182\/blood-2006-11-058800","article-title":"TIM-1 and TIM-3 enhancement of Th2 cytokine production by mast cells","volume":"110","author":"Nakae, S","year":"2007","journal-title":"Blood"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","article-title":"Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain","volume":"421","author":"Cua, DJ","year":"2003","journal-title":"Nature"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1126\/science.1148536","article-title":"Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells","volume":"318","author":"Anderson, AC","year":"2007","journal-title":"Science"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cellimm.2008.01.006","article-title":"The Tim-3 ligand galectin-9 negatively regulates CD8+ alloreactive T cell and prolongs survival of skin graft","volume":"250","author":"Wang, F","year":"2007","journal-title":"Cell Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.4049\/jimmunol.155.8.3716","article-title":"Cytotoxic effect of TNF and lymphotoxin on T lymphoblasts","volume":"155","author":"Sarin, A","year":"1995","journal-title":"J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2249.2005.02876.x","article-title":"FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn\u2019s disease","volume":"141","author":"Kelsen, J","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1073\/pnas.0408679102","article-title":"Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion","volume":"102","author":"Zelenay, S","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.clim.2007.08.003","article-title":"Characterization of FOXP3+CD4+ regulatory T cells in Crohn\u2019s disease","volume":"125","author":"Saruta, M","year":"2007","journal-title":"Clin Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.4049\/jimmunol.173.5.3119","article-title":"CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells","volume":"173","author":"Makita, S","year":"2004","journal-title":"J Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00535-007-2156-3","article-title":"Decreased numbers of FoxP3-positive and TLR-2-positive cells in intestinal mucosa are associated with improvement in patients with active inflammatory bowel disease following selective leukocyte apheresis","volume":"43","author":"Muratov, V","year":"2008","journal-title":"J Gastroenterol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/ibd.21229","article-title":"Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximab","volume":"16","author":"Li, Z","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1053\/j.gastro.2005.03.043","article-title":"Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease","volume":"128","author":"Maul, J","year":"2005","journal-title":"Gastroenterology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/MPG.0b013e3181e4d323","article-title":"Peripheral and intestinal CD4+ T cells with a regulatory phenotype in pediatric patients with inflammatory bowel disease","volume":"51","author":"La Scaleia, R","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1189\/jlb.0609382","article-title":"Human defensins and LL-37 in mucosal immunity","volume":"87","author":"Doss, M","year":"2010","journal-title":"J Leukoc Biol"},{"key":"ref48","first-page":"27","article-title":"Immunomodulatory properties of defensins and cathelicidins","volume":"306","author":"Bowdish, DM","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.4049\/jimmunol.163.12.6718","article-title":"Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium","volume":"163","author":"O\u2019Neil, DA","year":"1999","journal-title":"J Immunol"}],"container-title":["Gut and Liver"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/pdf.medrang.co.kr\/ekjg\/ekjg009-03-13.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T15:16:21Z","timestamp":1689434181000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.gutnliver.org\/journal\/view.html?doi=10.5009\/gnl13408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,23]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5,23]]}},"alternative-id":["10.5009\/gnl13408"],"URL":"https:\/\/doi.org\/10.5009\/gnl13408","relation":{},"ISSN":["1976-2283","2005-1212"],"issn-type":[{"value":"1976-2283","type":"print"},{"value":"2005-1212","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,23]]}}}